Resource Logo
NLM AIDSLINE

HIV infection at outcome of pregnancy in the Paris area, France.




 

Lancet. 1992 Sep 19;340(8821):707-9. Unique Identifier : AIDSLINE

The prevalence of HIV infection in women at end of pregnancy, irrespective of outcome, was determined in a comprehensive survey of both women and medical centres during successive 4-week periods in four areas of the Paris region, France. Blood samples were tested anonymously for antibodies to human immunodeficiency virus (HIV)-1 and HIV-2. Of the 11,593 blood samples 0.40% (95% confidence interval [CI] 0.28-0.51) were positive for HIV-1 and 0.02% (95% binomial interval [BI] 0.002-0.065) for HIV-2. Seroprevalence was higher among women with ectopic pregnancy (2%) (95% BI 0.24-7.04); the rate in women having an elective or therapeutic abortion was more than twice that in those delivering babies (0.70% vs 0.28%, p less than 0.05, relative risk 2.54, 95% CI 1.36-4.75). Studies with neonatal HIV seroprevalence as a surrogate for HIV prevalence in pregnant women would underestimate prevalence in these women.

Abortion, Therapeutic Acquired Immunodeficiency Syndrome/COMPLICATIONS/*EPIDEMIOLOGY Female Human *HIV Seroprevalence Paris Pregnancy Pregnancy Complications, Infectious/*EPIDEMIOLOGY Pregnancy Outcome/*EPIDEMIOLOGY Pregnancy, Ectopic/EPIDEMIOLOGY Risk Factors Support, Non-U.S. Gov't JOURNAL ARTICLE



 




Information in this article was accurate in December 30, 1992. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.